Status:
COMPLETED
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will assess the efficacy and safety of intravenous (iv) or subcutaneous (sc) Mircera, administered with pre-filled syringes, as maintenance treatment for renal anemia in chronic kidney dise...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- chronic renal anemia;
- on dialysis therapy for at least 12 weeks before screening;
- receiving iv or sc epoetin for at least 8 weeks before screening.
Exclusion
- women who are pregnant, breastfeeding or using unreliable birth control methods;
- administration of another investigational drug within 4 weeks before screening, or during the study period.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
336 Patients enrolled
Trial Details
Trial ID
NCT00081484
Start Date
June 1 2004
End Date
March 1 2006
Last Update
November 2 2016
Active Locations (66)
Enter a location and click search to find clinical trials sorted by distance.
1
Covina, California, United States, 91723
2
Los Alamitos, California, United States, 90720
3
Los Angeles, California, United States, 90073
4
San Diego, California, United States, 92123